The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with pre-existing angiotensin II receptors

Biochim Biophys Acta. 1991 Dec 3;1133(1):107-11. doi: 10.1016/0167-4889(91)90248-v.


The proposal that the mas oncogene is an angiotensin receptor was evaluated in Xenopus oocytes injected with human and rat mas RNA transcripts, and during transient expression of mas in several cell lines. No evidence of mas-induced angiotensin II (AII) receptors or [Ca2+]i responses was observed in Xenopus oocytes or in most of the transfected cells. However, Cos-1 cells, which showed a small endogenous [Ca2+]i response to AII, exhibited a modest but reproducible enhancement of this response after mas transfection. Such responses were inhibited by [Sar1, Ala8]AII and [Sar1, Ile8]AII, but not by [D-Arg1, D-Pro2, D-Trp7,9, Leu11] substance P, an antagonist reported to inhibit mas-induced responses to AII in oocytes. These findings are not compatible with the proposal that the mas oncogene is an angiotensin receptor, but suggest that expression of mas leads to increased responsiveness of the endogenous AII signaling system.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Sarcosine-8-Isoleucine Angiotensin II / metabolism*
  • 1-Sarcosine-8-Isoleucine Angiotensin II / pharmacology
  • Angiotensin Receptor Antagonists
  • Animals
  • Calcium / metabolism*
  • Cell Line
  • Microinjections
  • Oncogenes*
  • Oocytes
  • RNA Precursors / metabolism*
  • Receptors, Angiotensin / metabolism*
  • Recombinant Proteins*
  • Saralasin / metabolism*
  • Saralasin / pharmacology
  • Signal Transduction
  • Substance P / analogs & derivatives
  • Substance P / pharmacology
  • Transfection
  • Xenopus


  • Angiotensin Receptor Antagonists
  • RNA Precursors
  • Receptors, Angiotensin
  • Recombinant Proteins
  • Substance P
  • substance P, Arg(1)-Pro(2)-Trp(7,9)-Leu(11)-
  • 1-Sarcosine-8-Isoleucine Angiotensin II
  • Saralasin
  • Calcium